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Dynamical brain state transitions are critical for flexible working memory but the network 
mechanisms are incompletely understood. Here, we show that working memory entails brain-
wide switching between activity states. The stability of states relates to dopamine D1 
receptor gene expression while state transitions are influenced by D2 receptor expression 
and pharmacological modulation. Schizophrenia patients show altered network control 
properties, including a more diverse energy landscape and decreased stability of working 
memory representations. 
 
Working memory is an essential part of executive cognition depending on prefrontal neurons 
functionally modulated through dopamine D1 and D2 receptor activation (1-3). The dual-state 
theory of prefrontal dopamine function links the differential activation of dopamine receptors 
to two discrete dynamical regimes: a D1-dominated state with a high energy barrier favoring 
robust maintenance of cognitive representations and a D2-dominated state with a flattened 
energy landscape enabling flexible switching between states (4). Recent accounts extend the 
idea of dopamine’s impact on working memory from a local prefrontal to a brain-wide network 
perspective (5, 6), but the underlying neural dynamics and brain-wide interactions have 
remained unclear. 
Network control theory (NCT) can be used to model brain network dynamics as a function of 
interconnecting white matter tracts and regional control energy (7). Based on the 
connectome, NCT can be used to examine the landscape of brain activity states: that is, 
which states within a dynamic scheme would the system have difficulty accessing, and more 
importantly, which regions need to be influenced (and to what extent) to make those states 
accessible (8). Specifically, to quantify accessibility, we approximate brain dynamics locally 
by a simple linear dynamical system, ?̇?(𝑡) = 𝑨𝑥(𝑡) + 𝑩𝑢(𝑡), where x	(t) is the brain state 
inferred from functional magnetic resonance imaging (fMRI), A is a structural connectome 
inferred from DTI data, u is the control input, and B is a matrix describing which regions enact 
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control. To investigate, based on this conception, how the brain transitions between different 
cognitive states, we defined states as individual brain activity patterns related to a working 
memory condition (2-back) and to an attention control condition requiring motor response (0-
back) in a sample of 178 healthy individuals undergoing fMRI (Fig. S1; Online Methods). 
Further, we obtained individual structural connectomes from white matter by DTI fiber 
tracking, and computed the optimal control energy necessary to drive the dynamical system 
from the 0-back activity pattern to the 2-back pattern, or vice versa (Fig. S2). 
We defined the stability of both brain states as the inverse energy necessary to revisit that 
state, where the energy, loosely, is defined as the average size of the control signals u(t) 
needed to instantiate a specific trajectory in the dynamical system as defined above (see Eq. 
3 & 5 in Online Methods). As expected, the cognitively more demanding 2-back state was 
less stable (i.e., required higher energy for maintenance) than the control state (Fig. 1a; 
repeated measures ANOVA: main effect of 0- vs. 2-back stability: F(1,173) = 66.80, p < 
0.001, see Online Methods for details on all analyses). Further, the stability of the 2-back 
state was significantly associated with working memory accuracy (Fig. 1b; b = 0.274, p = 
0.006), suggesting that more stable 2-back network representations support higher working 
memory performance. We next investigated how the brain flexibly changes its activity pattern 
between states. Transitioning into the cognitively more demanding 2-back state required 
more control energy than the opposite transition (Fig. 1c; repeated measures ANOVA: 
F(1,174) = 27.98, p = 0.001). Other analyses suggested that prefrontal and parietal cortices 
steer both types of transitions, while default mode areas are preferentially important for the 
switch to the more cognitively demanding state (Fig. 1d; Online Methods). These results are 
in line with the assumed role of frontal-parietal circuits in steering brain dynamics (9) and 
shifting brain connectivity patterns (10); they also emphasize the importance of the 
coordinated behavior of brain systems commonly displaying deactivations during demanding 
cognitive tasks (11). 
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Following from the dual-state theory of network function, the stability of task-related brain 
states should be related to prefrontal D1 receptor status. To estimate individual prefrontal D1 
receptor expression, we utilized methods relating prefrontal cortex D1 and D2 receptor 
expression to genetic variation in their co-expression partner (Online Methods), thereby 
enabling us to predict individual dopamine receptor expression levels from genotype data 
across the whole genome (12, 13). We found that D1 (but not the D2) expression-related 
gene score predicted stability of both states (Fig. 2a; 0-back: b = 0.184, p = 0.034; 2-back: b 
= 0.242, p = 0.007, Online Methods), in line with the assumed role of D1-related signaling in 
maintaining stable activity patterns during task performance (4, 14). 
Independent of stability, switching between different activity representations should relate to 
dopamine D2 receptor function. Indeed, when controlling for stability as a nuisance covariate 
in the regression model, the control energy of both state transitions could be predicted by the 
D2 (but not the D1) receptor expression gene score (Fig. 2b; 0- to 2-back: b = -0.076, p = 
0.037; and trending for 2- to 0-back: b = -0.134, p = 0.068, Online Methods). This finding is 
particularly interesting, as it suggests that the function of D1 and D2 receptors are 
differentially, but cooperatively, involved in steering brain dynamics between different activity 
patterns, in line with previous research on D1 and D2 functioning in prefrontal circuits (4, 15). 
Our results thus far support the notion that the brain is a dynamical system in which the 
stability of a state is substantially defined by cognitive effort and modulated by D1 receptor 
expression, while transitions between states depend primarily on D2 receptor expression. If 
true, such a system should be sensitive to dopaminergic manipulation, and interference with 
D2-related signaling should reduce the brain’s ability to control its optimal trajectories, i.e. 
increase the control energy needed when switching between states. To test these 
hypotheses, we investigated an independent sample of healthy controls (n=16, Table S2) 
receiving 400 mg Amisulpride, a selective D2 receptor antagonist, in a randomized, placebo-
controlled, double-blind pharmacological fMRI study. As expected, we observed that greater 
control energy was needed for transitions under D2 receptor blockade (Fig. 2c; repeated 
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measures ANOVA with drug and transition as within-subject factors; main effect of drug: 
F(1,10) = 7.27, p = 0.022; drug-by-condition interaction: F(1,10) = 0.42, p = 0.665). We 
observed no effect on the stability of states; that is, the inverse control energy required to 
stabilize a current state (main effect of drug: F(1,8) = 0.715, p = 0.422, Table S3). 
Dopamine dysfunction, working memory deficits, and alterations in brain network 
organization are hallmarks of schizophrenia (16-19). We therefore tested for differences in 
the state stability and in the ability to control state transitions between schizophrenia patients 
and a healthy control sample balanced for age, sex, performance, head motion, and 
premorbid IQ (see Table S1). Stability in schizophrenia patients was reduced for the 
cognitively demanding working memory state (F(1,98) = 6.43, p = 0.013), but not for the 
control condition (F(1,98) = 0.052, p = 0.840, Table S3). Control energy needed for the 0- to 
2-back transition was significantly higher in schizophrenia (Fig. 2d; F(1,98) = 5.238, p = 
0.024), while the opposite transition showed no significant group difference (ANOVA: F(1,98) 
= 0.620, p = 0.433, Table S3), in line with clinical observations that D2 blockade does not 
ameliorate cognitive symptoms in schizophrenia (20). These results suggest that the brain 
energy landscape is more diverse in schizophrenia, making the system more difficult to steer 
appropriately. To further strengthen this notion, we estimated the variability in suboptimal 
(higher energy) trajectories connecting different of cognitive states (Online Methods). We 
expected that in a diversified energy landscape, the variation of trajectories around the 
minimum-energy trajectory should be larger, implying that small perturbations may have a 
more substantial impact. In line with our hypothesis, we found that the variability in such 
perturbed trajectories was indeed increased in schizophrenia (rm-ANOVA: main effect of 
group: F(1,98) = 4.789, p = 0.031, Online Methods).  
Several aspects of our work require special consideration. Firstly, to relate brain dynamics to 
cognitive function, we focus on discrete brain states where each state is summarized by a 
single brain activation patterns rather than linear combination of multiple brain activity 
patterns. Secondly, although we could demonstrate a link between brain dynamics, 
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measured by means of control energy, and predicted prefrontal dopamine receptor 
expression, the link is indirect and requires confirmation by direct measurements. Thirdly, we 
cannot exclude the possibility that disorder severity, duration, symptoms or medication may 
have influenced network dynamics in schizophrenia patients, although our supplemental 
analyses do not support this conclusion (Online Methods). Finally, while the sample sizes of 
our pharmacological and patient study are rather small, we were able to show comparable 
effects of dopaminergic manipulation on control properties using a second (Online Methods), 
further supporting the validity of the underlying rationale. 
In summary, our data demonstrate the utility of network control theory for the non-invasive 
investigation of the mechanistic underpinnings of (altered) brain states and their transitions 
during cognition. Our data suggest that engagement of working memory involves brain-wide 
switching between activity states and that the steering of these network dynamics is 
differentially, but cooperatively, influenced by dopamine D1 and D2 receptor function. 
Moreover, we show that schizophrenia patients show reduced controllability and stability of 
working memory network dynamics, consistent with the idea of an altered functional 
architecture and energy landscape of cognitive brain networks. 
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Figures 
Figure 1: 
 
Controllability and stability of brain dynamics during working memory 
A) The stability of the 2-back state reflecting working memory activity is lower than that of the 
0-back state reflecting motor and basic attention control activity (F(1,173) = 66.80, p < 
0.001). Red lines indicate mean values and boxes indicate one standard deviation of the 
mean. B) Associations of 2-back stability with working memory performance (accuracy: b = 
0.274, p = 0.006; covarying for age, sex, and mean activity). C) Steering brain dynamics from 
the control condition to the working memory condition requires more control energy than vice 
versa (F(1,174) = 27.98, p < 0.001). D) Unique and common sets of brain regions contribute 
most to the transition from 0-back to 2-back and the transition from 2-back to 0-back 
transitions, respectively. For illustrative purposes, we projected the computed control impact 
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of each brain region (Online Methods) for the respective transitions on a 3D structural 
template, displaying the 20% highest for each transition.  
Figure 2: 
 
Dopamine receptor expression and pharmacological modulation impact whole brain 
dynamics 
A) Genetic scores predicting DRD1 expression in prefrontal regions positively predict stability 
of both brain states (0-back: b = 0.184, p = 0.034; 2-back: b = 0.242 p = 0.007; age, sex, 
mean brain state activity, first 5 genetic PCA components as covariates of non-interest). B) 
Genetic scores predicting DRD2 expression in prefrontal regions negatively predict control 
energy for both brain state transitions (0-back to 2-back: b = -0.076, p = 0.037; and trend 
wise for 2-back to 0-back: b = -0.134, p = 0.068; age, sex, mean brain activity difference, first 
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5 genetic PCA components, stability of 0-back and 2-back as covariates of non-interest). C) 
Amisulpride increases control energy for transitions in comparison to placebo (main effect of 
drug: F(1,10) = 7.27, p = 0.022; interaction drug by condition: F(1,10) = 0.42, p = 0.665, 
activity difference, drug order, and sex as covariates of non-interest). Black lines indicate 
mean values and boxes indicate one standard deviation of the mean. D) Schizophrenia 
patients need more control energy when transitioning into the working memory condition than 
matched healthy controls (F(1,98) = 5.238, p = 0.024, age, sex, tSNR and mean activity as 
covariates of non-interest), but not vice versa.  
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1. Participants and study design 
All participants provided written informed consent for protocols approved by the Institutional Review Board 
of the medical faculty in Mannheim. For the first study including healthy controls and patients with 
schizophrenia, a total of 202 subjects (178 healthy controls, 24 schizophrenia patients) were included (see 
Table S1). General exclusion criteria in controls included the presence of a lifetime history of psychiatric, 
neurological, or significant general medical illness, pregnancy, a history of head trauma, and current alcohol 
or drug abuse. The patients were recruited from the Department of Psychiatry and Psychotherapy at the 
Central Institute of Mental Health in Mannheim and via local advertisements. A trained psychiatrist or 
psychologist verified the diagnosis of schizophrenia based on ICD-10 criteria. 
 
Neuropsychological characterization of healthy controls included the trail-making-test B (TMT-B) (1) and the 
German multiple-choice vocabulary intelligence test (MWT-B) (2) as a measure of premorbid IQ. Clinical 
characterization included the assessment of current symptom severity using the Positive and Negative 
Symptom Scale (PANSS) (3), Beck’s Depression Inventory (4), measures of global functioning in daily life 
(global assessment of function (GAF)) and current antipsychotic medication dosage (converted into 
chlorpromazine dose equivalents (CPZE)). 
 
For the second, pharmacological intervention study, 17 healthy individuals completed a subject- and 
observer-blind, placebo-controlled, randomized three-period cross-over study (see Table S2). Exclusion 
criteria included a regular consumption of drugs or history of drug or alcohol abuse; systolic blood pressure 
(SBP) greater than 140 or less than 90 mm Hg, and diastolic blood pressure (DBP) greater than 90 or less 
than 50 mm Hg; notable resting bradycardia (heart rate (HR) <40 bpm) or tachycardia (HR >90 bpm); use of 
any medication or herbal remedies taken within 14 days prior to randomization into the study or 5 times the 
elimination half-life of the medication, clinically significant abnormalities in laboratory test results (including 
hepatic and renal panels, complete blood count, chemistry panel and urinalysis): a history or presence of 
clinically significant ECG abnormalities (e.g. PQ/PR interval >210 ms, QTcF >450 ms) or cardiovascular 
disease (e.g. cardiac insufficiency, coronary artery disease, cardiomyopathy, hypokalemia, congestive heart 
failure, family history of congenital long QT syndrome, family history of sudden death); any personal or familial 
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history of seizures, epilepsy or other convulsive condition, previous significant head trauma, or other factors 
predisposing to seizures; disorders of the central nervous system, cerebrovascular events, Parkinson’s 
disease, migraine, depression, bipolar disorder, anxiety, any other psychiatric disorders or behavioral 
disturbances; regular smoking (>5 cigarettes, >3 pipe-fulls, >3 cigars per day); habitual caffeine consumption 
of more than 400 mg/d (approximately 4 cups of coffee or equivalent); a history or evidence of any clinically 
significant endocrinological, hepatic, renal, autoimmune, pulmonary, gastrointestinal, urogenital, oncological, 
hematological or any other disease; or a body mass index (BMI) of over 30 or below 22. 
Participants were invited for a fixed interval of 7 days with each scanning session taking place at 
approximately the same time of day. On each of three scanning visits, individuals either received a single 
oral dose of 400 mg Amisulpride, 3 mg Risperidone or Placebo. MRI scanning took place 2 hours after drug 
administration, with the N-back paradigm commencing approximately 10 min after the start of the scan. 
One subject was excluded from the analysis due to an excessive body-mass index (BMI > 30). 
 
2. Data acquisition 
2.1. fMRI 
For the first study, BOLD fMRI was performed on a 3T Siemens Trio (Erlangen, Germany) in Mannheim, 
Germany. Prior to the acquisition of functional images, a high-resolution T1-weighted 3D MRI sequence 
was conducted (MPRAGE, slice thickness=1.0 mm, FoV = 256 mm, TR = 1570ms, TE = 2.75 ms, TI = 
800ms, α = 15°). Subsequently, functional data was acquired during performance of the N-back paradigm 
using an echo-planar imaging (EPI) sequence with the following scanning parameters: TR/ TE = 2000/30 
ms, α =80°, 28 axial slices (slice-thickness = 4 mm + 1 mm gap), descending acquisition, FoV = 192 mm, 
acquisition matrix = 64 x 64 128 volumes. 
For the second study, BOLD fMRI was performed on a 3T Siemens Trio Scanner (Erlangen, Germany) 
using an echo-planar imaging (EPI) sequence with the following parameters: TR = 1790 ms, TE = 28 ms, 
34 axial slices per volume, voxel size = 3 x 3 x 3 mm, 1 mm gap, 192 x 192 mm field of view, 76° flip angle, 
descending acquisition. 
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The visual N-back paradigm is a well-established and reliable working memory task consisting of a high 
memory load (2-back) and an attention control condition requiring motor response (0-back) (5-7).  
Specifically, a diamond-shaped stimulus containing a number from 1 to 4 was presented every 2 seconds 
(see Figure S1). In the 0-back condition, subjects were required to press the button on the response box 
corresponding to the number currently displayed on the presentation screen. In the 2-back condition, 
subjects were required to press the button on the response box corresponding to the number presented 
two stimuli before the number currently displayed on the presentation screen. Stimuli were presented in 
alternating blocks of either 0-back or 2-back conditions. In each condition block, 14 stimuli were presented. 
Each condition block was repeated 4 times. Task performance was measured by accuracy (defined as the 
percent of correct answers) and reaction time (defined as the time span between stimulus onset and button 
press) for each condition separately. 
2.2. Diffusion Tensor Imaging (DTI) 
DTI data were acquired by using spin echo EPI sequences with the following parameters: TR 14000ms, TE 
86ms, 2mm slice thickness, 60 non-collinear directions, b-value 1000 s/mm2, 1 b0 image, FOV 256 mm. 
 
3. Atlas construction 
To combine structural and functional brain imaging data, we first constructed a brain atlas that equally well 
respects functional and anatomical features. We transformed a recently published multimodal atlas (8) into 
a volumetric format by projecting its FreeSurfer pial cortex coordinates into standard MNI space. A grey 
matter prior probability map (thresholded at 0.3) as provided by SPM was used to define relevant voxels. 
Voxels were labeled by choosing the closest label with maximum distance of 4 mm. Since the published 
multimodal atlas does not cover all subcortical regions of interest (e.g. amygdala, thalamus), we 
complemented it with subcortical structures from the Harvard-Oxford atlas as implemented in FSL (9). 
Combining the two atlases resulted in 374 regions that covered cortical and subcortical structures. A full list 
of regions included in the combined atlas can be found in Supplemental Table S3. 
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4. Connectome construction 
For the DTI data, the following preprocessing steps were performed with standard routines implemented in 
the software package FSL (9): i) correction of the diffusion images for head motion and eddy currents by 
affine registration to a reference (b0) image, ii) extraction of non-brain tissues (10), and iii) linear diffusion 
tensor fitting. After estimation of the diffusion tensor, we performed deterministic whole-brain fiber tracking 
as implemented in DSI Studio using a modified FACT algorithm (11). For each subject, 1,000,000 
streamlines were initiated. Streamlines with a length of less than 10 mm were removed (12). For the 
construction of structural connectivity matrices, the brain was parcellated into 374 regions. To map these 
parcellations into subject space, we applied a nonlinear registration implemented in DSI Studio. We 
estimated the structural connectivity between any two regions of the atlas by using the mean fractional 
anisotropy values between respective brain regions. This procedure resulted in a weighted adjacency 
matrix A whose entries Aij reflect the strength of structural connectivity between two brain regions. 
 
5. Brain state definition 
Because we were interested in investigating how the brain controls and transitions between global brain 
states underlying circumscribed cognitive processes (such as those supporting working memory, attention, 
and motor behavior), we defined brain states as stationary patterns of activity during execution of these 
processes. It is important to note that the temporal resolution of fMRI and the design of the N-back task 
limits the investigation of differential cognitive processes contributing to memory performance on fast time 
scales. Therefore, we cannot investigate the detailed temporal dynamics of working memory processes. 
However, our simplified design allows us to extract meaningful brain states elicited by a controlled cognitive 
process and therefore enables us to relate brain dynamics to cognitive function. 
Specifically, we defined individual brain states as spatial patterns of beta estimates associated with activity 
across brain regions of interest during both conditions of the N-back task (13). For that purpose, after 
standard preprocessing procedures in SPM12/8 (including realignment to the mean image, slice time 
correction, spatial normalization into standard stereotactic space, resampling to 3 mm isotropic voxels, and 
smoothing with an 8 mm full-width at half-maximum Gaussian Kernel) (5, 6, 14), we estimated standard 
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first-level general linear models for the N-back task, separately for each individual. Except for the SPM 
version, both studies followed the same preprocessing procedure. These GLM models included regressors 
for the 0-back and 2-back conditions of interest, as well as the 6 motion parameters as regressors of non-
interest. To define the brain activity pattern associated with each condition of the task, we extracted GLM 
(beta) parameter estimates for the 0-back and 2-back conditions separately (13) and we averaged them 
across all voxels in each of the 374 regions without applying any threshold. This procedure yielded a 374 
by 1 vector for each condition (x0-back, x2-back) per subject representing how strongly the BOLD response in 
each brain region was associated with the working memory (2-back) or the motor control condition (0-
back), respectively. These vectors (x0-back, x2-back) defined the final and target brain states for the following 
network control analyses. 
 
6. Network control theory 
6.1. Optimal control theory framework 
To model the transition between 0-back and 2-back brain states, we used the framework of optimal control, 
following prior work (15-17) implemented in MATLAB. Based on individual brain states X=[x1,…xn] (in our 
case simplified to n = 2 states: 0-back and 2-back, see above) and a structural brain network A for each 
subject, we approximated the local brain dynamics by a linear continuous-time equation: 
(1)  ẋ(t)	=	A	x(t)	+	B	u(t)		
to model the flow among task-related brain activity states. In the model, x(t) is the state of the system at 
time t, A is the wiring diagram of the underlying network, B denotes an input matrix defining the control 
nodes, and u(t) is the time-dependent control signal (17, 18). Note that while the initial state (x0) and the 
target state (xT) are empirically defined, any states of the system at other times are virtual intermediate 
steps in the trajectories of the state-space model. The problem of finding an optimal control energy u* that 
induces a trajectory from an initial state x0 to a target state xT reduces to the problem of finding an optimal 
solution to the minimization problem of the corresponding Hamiltonian: 
(2) min[H(p,	x,	u,	t)	=	xTx	+	ñuTu	+	pT	(Ax	+	Bu)]	(15). 
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For simplicity, we set the input matrix B	=	IN´N, the identity matrix, allowing all brain regions to be 
independent controllers (16, 18). 
6.2. Control energy, stability, and impact 
Control energy for each node ki,	i	=	1…m (m = total number of brain nodes), was defined as 
(3)   𝐸𝑘𝑖 = ∫ D𝑢∗𝑘𝑖(𝑡)D2𝑑𝑡𝑇𝑡=0 , 
i.e. the squared integral over time of energy input that the node has to exhibit to facilitate the transitions 
from the initial state to the target state (15, 16, 18). While the neurobiological foundations of control 
properties in the brain are not yet well understood, control energy can be interpreted as the effort of a brain 
region needed to steer the activity pattern of itself and its connected brain regions into the desired final 
activation state, for example by tuning their internal firing or activity patterns by recurrent inhibitory 
connections. Accordingly, the total control energy for the entire brain was defined as the sum of all control 
energy across all nodes 
(4) 𝐸 = ∑ 𝐸KLMNOP , 
yielding one value for each transition per subject. To ensure a normal distribution of metric values for 
subsequent statistical testing, we applied a logarithmic transformation (base 10) to the control energy(16).  
From the control energy, we can also obtain the control stability and control impact. Stability was defined as 
(5)  𝑆 = PRSTUV(WXYZX[), 
i.e. the inverse control energy needed to maintain a state, or in other words, the control energy needed to 
go, e.g., from 2-back to 2-back (18). To investigate the influence that a single brain region has on the entire 
system’s dynamics during state trajectories, we computed the control impact of each node by iteratively 
removing one brain region from the network and re-computing the change in control energy (15). 
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6.3. Suboptimal trajectories 
To investigate the energy landscape surrounding the minimum energy (in this sense ‘optimal’) trajectories, 
we quantified the variability of suboptimal trajectories by adding subtle random perturbation to the minimum 
energy trajectories over 200 iterations. Note that we employed a discrete-time dynamical system rather 
than a continuous-time system for these analyses, as discrete-time systems are computationally more 
tractable. To discretize our linear continuous-time system, we employed the following transformations 
(6)  𝑨] 	≜ 	 𝑒𝑨 a` and 
(7)  𝑩] ≜ 	c∫ 𝑒d( a`ef)a`g 𝑑𝜏i𝑩, 
where 𝑨]	and	𝑩]  are the corresponding structural matrix and control input matrix in a discrete time system 
and Ts is the sampling time. As there is no prescriptive way to choose Ts, we estimated 𝑇m = 	 PPg 	𝑅𝑇, where RT is the rise time of its fastest mode, i.e. the time that the system requires to go from 10% to 90% of its 
fastest step response. In the resulting discrete-time dynamical system 
(8)  ?̅?	(𝑡 + 1) = 	𝑨]?̅?(𝑡) + 𝐵s𝑢s(𝑡), 
at each discrete time step t, we applied a principal component analysis (PCA) to the cloud of suboptimal 
points to reduce dimensionality. Because the previous simulations show that the first PCA component 
explains more than 90% of variance, we continued by using the first component as a summary measure of 
suboptimal trajectories. To estimate the relative distance between suboptimal and optimal trajectories, we 
computed the percentage of variation of the maximum distance of the projected suboptimal points on the 
first principal component from the optimal one. This procedure resulted in a normalized measure giving the 
percentage of deviations for the 200 suboptimal trajectories from the optimal trajectory. Due to the heuristic 
nature of the algorithm applying a random perturbation, results can vary from run to run. Therefore, to 
increase replicability of our results, we repeated our analysis 10 times per subject (10*200 = 2,000 
suboptimal trajectories per subject). 
Because DTI data was not acquired during the pharmacological intervention study, we used the average 
connectivity matrix across all healthy subjects from study 1 to model the transition between individual brain 
states in the pharmacological intervention study. 
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7. Gene based polygenic co-expression indices  
7.1. Genotyping, imputation and quality control 
In this study, we used human GWAS data of 63 healthy subjects who were genotyped using HumanHap 
610 and 660w Quad BeadChips. For all subjects, standard quality control (QC) and imputation were 
performed using the Gimpute pipeline (Chen, Lippold et al. 2018) and the following established QC steps 
were applied. Step 1: Determine the number of male subjects for each heterozygous SNP of the 
chromosome 23 and remove SNPs whose number is larger than 5% of the number of male samples. Step 
2: Determine the number of heterozygous SNPs on X chromosome for each male sample, and remove 
samples that have the number of heterozygous SNPs larger than 10. Step 3: Remove SNPs with missing 
genotyping rate > 5% before sample removal. Step 4: Exclude samples with missingness >= 0.02. Step 5: 
Exclude samples with autosomal heterozygosity deviation |Fhet| >= 0.2. Step 6: Remove SNPs with the 
proportion of missing genotyping > 2% after sample removal. Step 7: Remove SNPs if the Hardy-Weinberg 
equilibrium exact test P-value was < 1 x 10-6. Step 8: Principal component analysis (PCA) was applied to 
detect population outliers. Imputation was carried out using IMPUTE2/SHAPEIT (19-21), with a European 
reference panel for each study sample in each 3 Mb segment of the genome. This imputation reference set 
is from the full 1000 Genome Project dataset (August 2012, 30,069,288 variants, release “v3.macGT1”). 
The length of the buffer region is set to be 500 kb on either side of each segment. All other parameters 
were set to default values implemented in IMPUTE2. After imputation, SNPs with high imputation quality 
(INFO >= 0.6) and successfully imputed in >= 20 samples were retained.  From the final well-imputed 
dataset with 63 subjects, we extracted 8 SNPs for DRD2 and 13 SNPs for DRD1 (22-24). For the 
subsequent genetic imaging analyses, we only used subjects for whom both data modalities (DTI and fMRI 
data) were available. 
7.2. Polygenic co-expression index calculation  
Previous publications have shown that gene sets defined using co-expression networks and selected for their 
association with the genes DRD1 and DRD2 provided replicable predictions of n-back-related brain activity 
and behavioral indices (23, 25-27). Weighted Gene Co-expression Network Analysis [WGCNA (28)] applied 
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on the Braincloud dataset (N=199) of post-mortem DLPFC gene expression (29) identified 67 non-
overlapping sets of genes based on their expression pattern. The co-expression gene sets including DRD1 
and DRD2 were summarized into Polygenic Co-expression Indices (PCIs) based on SNPs that predicted co-
expression of these genes (called co-expression quantitative trait loci, or co-eQTLs). 
PCIs are a proxy for the assessment of the genetic component of gene transcription co-regulation and are 
computed as a weighted average of the effect of all genotypes of an individual among those selected in the 
data mining study as co-eQTLs. The effect of individual SNPs is computed as the difference between the 
gene co-expression distribution of minor allele carriers (heterozygotes and homozygotes) and that of major 
allele homozygotes, using common tools from signal detection theory (30). Genotype weights, therefore, 
represent the deviation in gene co-expression from a reference distribution and are not constrained by 
allele dose. For each genotype of each SNP we computed an index, called A’, proportional to the 
expression of the gene of interest (DRD1 or DRD2) within its co-expression module. The A’ index is less 
dependent than d‘ on the assumption of a normal distribution of gene expression in each genotypic 
population (25). Both PCI-based predictions were significantly replicated in an independent post-mortem 
dataset, while controlling for ethnicity. The translational effect of these two scores on brain activity during n-
back has been assessed and replicated across multiple samples, which combined amount to approximately 
600 participants (22-24). 
It is important to note that these dopamine-related genetic effects are large in magnitude compared to 
those estimated by polygenic risk score approaches that focus on epidemiological data, rather than on 
molecular processes. The DRD2-PCI we developed (23) yielded an effect size f = 0.30 in our n-back 
discovery sample (required sample size to obtain 80% power with α = 0.05 and covariates as in the current 
work: N = 71). Results were replicated in an independent fMRI dataset collected at a different institution 
with f = 0.20 (required sample size computed as above: N = 156). Our follow-up work on the DRD2-PCI 
(26) considered two datasets of 50 individuals each and yielded a minimum effect size f = 0.28 (in the 
replication sample; required sample size computed as above: N = 81). The DRD1-PCI was also tested in 
two independent samples (25), yielding a minimum effect size f = 0.37 (in the replication sample; required 
sample size computed as above: N = 46). Taken together, these published results show that the effects of 
these polygenic indices on n-back activity in the prefrontal cortex are relatively large, with sizes ranging 
between 0.20 and 0.37 and with required samples ranging from 46 to 156 individuals. Importantly, the 
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DRD2-PCI was also tested in a small sample of 29 patients with SCZ and yielded results consistent with 
the effects discovered in healthy controls (23). Although the required sample sizes were computed based 
on the top cluster, it should be borne in mind that the technique we used in this work employs the entire 
brain, and therefore (i) is not subject to correction for multiple comparisons, as reflected in the uncorrected 
alpha used for the power calculations and (ii) benefits from the greatest possible amount of information 
about brain states. 
 
8. Statistical inference 
Statistical inference was performed using the Statistical Package for the Social Sciences 24 (IBM SPSS 
Statistics for Windows, Version 24). All statistical comparisons were performed while controlling for age and 
sex and were tested two-sided. Because we were interested in control properties of brain state transitions 
independent of differences in the amount of mere activation, we controlled for the respective parameters 
reflecting the individual differences in activations in all analyses involving control properties. In particular, 
for all analyses involving stability measures, we additionally controlled for the average brain energy defined 
as the GLM parameter estimates over all regions in the 0-back and 2-back conditions. As the control 
energy of a transition depends highly on the absolute difference in energy between its initial state and its 
final state (i.e. in our case the brain-wide activation difference between both task conditions) and as we 
were interested in the unique control properties independent of traditional activation differences, we 
additionally controlled for the difference in the mean baseline energy in each analysis involving control 
energy. Baseline energy was defined as the absolute average difference in the unthresholded GLM 
parameter estimates over all regions between 0-back and 2-back conditions. As the same arguments apply 
to stability measures, we controlled for the respective baseline energy of each condition in each analysis 
involving stability. 
In all analyses involving polygenic scores for D1-/D2-expression, we further used the first 5 principal 
components from the PCA on the linkage-disequilibrium pruned set of autosomal SNPs to control for 
population stratification. Differences between control energy/stability of both conditions were assessed 
using repeated-measures ANOVA with condition as a within-subject factor. Drug effects were modeled 
using a repeated measures ANOVA with drug and condition as within-subject factors. As healthy control 
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and schizophrenia patients differed in one of the quantified DTI imaging quality parameters (tSNR, see 
Table S1), we also controlled for tSNR in each analysis involving both groups.  
 
9. Control analyses 
9.1. Null models of structural brain networks  
To study the impact of structural brain networks on control properties, we repeated the computation of 
control energy using a randomized null model of the individuals’ structural brain networks that preserves 
the average weight, the strength distribution and the degree distribution. Null models were created using 
the null_model_und_sign function as implemented in the Brain Connectivity Toolbox 
(https://sites.google.com/site/bctnet/). In line with our expectation, control energy increased significantly for 
randomized networks in both groups (repeated measures ANOVA with null_model_vs_data and transition 
as within-subject factors, HC: main effect of null_model_vs_data, F(1,174) = 38.284, p < 0.001; SZ: F(1,20) 
= 3.561, p = 0.074), suggesting that human brain structural networks are in some form optimized to control 
brain state transitions, but schizophrenia patients tend to have less optimal, more random structural brain 
networks. 
9.2. Null models of spatial activity patterns 
To study the impact of the spatial distribution of activity patterns on control properties, we repeated the 
computation of control energy and spatially randomized individuals’ brain activation patterns. In line with 
our expectation, control energy increased significantly for randomized networks in both groups (repeated 
measures ANOVA with model_vs_data and transition as within-subject factors, HC: main effect of 
model_vs_data, F(1,174) = 6.995, p = 0.009; SZ: F(1,20) = 0.019, p < 0.0893), suggesting that the spatial 
distribution of brain activity patterns is important for minimizing control effort. 
9.3. Robustness to choice of parcellation scheme  
To demonstrate the robustness of the results to our choice of parcellation scheme, we repeated our 
analysis using a recently published functionally defined atlas comprising a similar number of areas (31). 
Specifically, we used the “Gordon” template (31) consisting of 333 regions that are functionally derived from 
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resting-state connectivity analyses. Data were reprocessed using the same pipeline as for the main 
analysis and all parameters were kept identical in the subsequent analysis. Notably, we replicated all main 
results (see Table S4), indicating that our reported findings are robust to the choice of parcellation scheme. 
9.4. Robustness to choice of edge definition 
To demonstrate the robustness of our results to our selection of connectivity measure, we repeated our 
analysis using the number of streamlines normalized by the respective size of the regions to construct 
structural connectivity matrices (15). All parameters were kept identical in the subsequent analysis. All main 
results could be replicated (see Table S4), indicating that our findings are robust to the choice of edge 
definition. 
9.5. Impact of medication and duration of illness on control properties 
In patients, the potential relationship between control energy and stability, antipsychotic drug dose 
(expressed in chlorpromazine equivalents (CPZE), n=20), and clinical parameters (illness duration, illness 
severity as indexed by global functioning (GAF) and Positive and Negative Symptom Scale (PANSS)) were 
explored using Pearson correlation. Neither the control energy for the 0-back to 2-back transition nor the 
opposite transition or the stability of either state were significantly associated with CPZE (N = 20, 0- to 2-
back: r = 0.078, p = 0.767; 2- to 0-back: r = 0.320, p = 0.210; 0- back stability: r = 0.150, p = 0.564; 2- back 
stability: r = 0.096, p = 0.713), with illness duration (N = 23, 0- to 2-back: r = 0.017, p = 0.937; 2- to 0-back: 
r = -0.226, p = 0.299; 0- back stability: r = 0.110, p = 0.644; 2- back stability: r = 0.281, p = 0.230), or with 
GAF (N = 24, 0- to 2-back: r = -0.086, p = 0.690; 2- to 0-back: r = -0.254, p = 0.230; 0- back stability: r = -
0.135, p = 0.570; 2- back stability: r = 0.066, p = 0.793). 
9.6. Pharmacological validation using Risperidone 
To demonstrate the robustness of our pharmacological intervention of dopaminergic signaling, we 
additionally analyzed the data of the Risperidone condition in the same subjects. Risperidone also 
preferentially targets D2 receptors, but also affects D1, adrenergic, serotoninergic and histaminergic 
pathways. Using the same models and covariates as in the main analysis, we detected a trend-wise 
increase in control energy needed for both transitions (repeated measures ANOVA with drug and transition 
as within-person factors; main effect of drug: F(1,10) = 3.490, p = 0.091; drug-by-condition interaction: 
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F(1,10) = 0.238, p = 0.636; activity difference, drug order, and sex as covariates of no interest), but no 
effect on stability (F(1,8) = 0.105, p = 0.334; mean brain activity, sex, and drug order as covariates of no 
interest). Although these results showed only trend-wise significance, likely due to the lower D2-specificity 
of Risperidone, the detected pattern was conserved across drugs, validating the proposed underlying 
concepts. 
9.7. Null results for gene score and imaging associations 
As mentioned in the main text, D1 receptor expression-related gene scores predicted stability of both states 
(0-back: b = 0.184, p = 0.034; 2-back: b = 0.242 p = 0.007), but not D2 receptor expression-related gene 
scores (0-back: b = 0.153, p = 0.109; 2-back: b = -0.01 p = 0.924). In turn, the control energy of both state 
transitions could be predicted by the D2 receptor expression-related score (0- to 2-back: b = -0.076, p = 
0.037; and trending for 2- to 0-back: b = -0.134, p = 0.068), but not by the D1 receptor expression-related 
gene score (0- to 2-back: b = -0.037, p = 0.324; 2- to 0-back: b = -0.06, p = 0.418). 
9.8. Suboptimal trajectories 
As mentioned in the main text, the variability in suboptimal trajectories was greater in schizophrenia (rm-
ANOVA: main effect of group: F(1,98) = 4.789, p = 0.031, controlling for age, sex, DTI tSNR ,brain state 
energy difference). These results remained significant after additionally accounting for the stability of both 
states and for the control energy of both transitions (rm-ANOVA: main effect of group: F(1,95) = 11.2, p = 
0.001). 
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10. Supplementary figures 
10.1. Figure S1: N-back task design 
 
Design of the N-back task: Stimuli were presented in blocks of either 0-back (left) or 2-back (right) 
conditions. There was no additional control or resting condition. In the 0-back condition, subjects were 
instructed to press the button on the response box corresponding to the number currently displayed on the 
presentation screen. Here, the red numbers next to the screen images on the left indicate correct 
responses. In the 2-back condition, subjects were instructed to press the button on the response box 
corresponding to the number presented two stimuli before the number currently displayed on the 
presentation screen. Here, the red numbers next to the screen images on the right indicate the correct 
responses. Each condition block lasted 30 seconds and was repeated four times in an interleaved manner 
as shown on the bottom of the figure. 
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10.2. Figure S2: Network control theory concept and methods 
 
 
A summary of the methods to assess brain dynamics using network control theory. We used a multimodal 
atlas, and applied it to both diffusion tensor imaging data to obtain a structural connectome, and to 
functional magnetic resonance imaging data to obtain activation patterns during a 0-back motor and 
attention control task and during a 2-back working memory task. Finally, we use network control theory to 
explain transitions between 0-back and 2-back states based on the underlying structural connectome.  
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11. Supplementary tables 
 
11.1. Table S1: Characteristics of the healthy control and patient samples 
 
 Healthy 
controls 
(n = 178) 
Matched 
controls 
(n = 80) 
Schizophrenia 
patients 
 (n = 24) 
t or χ² 
value 
P value 
Demographic 
information 
     
Age (year) 33.05 ± 10.98 35.49 ± 10.55 32.25 ± 10.33 1.32 0.188 
Sex (male / female) 93 / 85 46 / 34 18 / 6 2.39 0.122 
Years of education  13.66 ± 2.41 13.65 ± 2.73 11.68 ± 1.45  2.72 0.008 
Psychological 
assessments 
     
MWTB 30.74 ± 3.84 30.32 ± 4.83 29.13 ±3.27 1.11 0.272 
PANSS positive n.a n.a. 12.50 ± 6.76 - - 
PANSS negative n.a n.a 15.17 ± 6.76 - - 
BDI n.a n.a. 12.42 ± 7.71 - - 
Years of illness n.a. n.a. 10.22 ± 9.32 - - 
fMRI task 
performance  
     
Accuracy (%) 80.10 ± 18.35 68.75 ± 19.33 65.54 ± 19.79 0.70 0.479 
Reaction time (ms) 496.15 ± 279.50 589.21 ± 286.80 627.06 ± 306.99 -0.6 0.553 
Imaging quality 
parameters 
     
fMRI: mean frame-
wise displacement 
(mm) 
0.15 ± 0.06 0.18 ± 0.07 0.20 ± 0.09 -1.11 0.270 
DTI: mean absolute 
root-mean-square 
displacement (mm) 
1.27 ± 0.74 1.37 ± 0.89 1.34 ± 0.59 0.18 0.860 
DTI: tSNR 5.61 ± 0.45 5.52 ± 0.49 5.26 ± 0.49 2.21 0.028 
 
Abbreviations: MWTB = Mehrfach Wortschatz Intelligenztest B, a German multiple-choice vocabulary 
intelligence test as a measure of premorbid IQ; PANSS = positive and negative symptom scale; BDI = 
Beck’s depression inventory; DTI = diffusion tensor imaging; tSNR temporal signal-to-noise. 
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11.2. Table S2: Sample characteristics of the pharmacological study 
 
 Healthy control (n = 16) t value P value 
 Placebo Amisulpride   
Demographic 
information 
    
Age (year) 26.63 ± 5.34   
Sex (male / 
female) 
8 / 8   
fMRI task 
performance * 
    
Accuracy (%) 89.32 ± 10.00 85.68 ± 11.66 1.27 0.223 
Reaction time (ms) 347.42 ± 104.26 365.40 ± 142.54 -0.582 0.569 
Head motion 
parameters 
    
fMRI: Mean frame-
wise displacement 
(mm) 
0.124 ± 0.03 0.126 ± 0.04 -0.301 0.767 
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11.3. Table S3: Statistical details for the main findings and replication analyses 
  Glasser Gordon 
  FA count FA 
Result 
df F or t  p-val df F or t p-val df F or t p-val 
  
(stand 
beta)     
(stand 
beta)     
(stand 
beta)   
General properties of 
control             
stability 0 back > 2 back 1,173 66.80 < 0.001 1,173 60.50 <0.001 1,173 56.846 <0.001 
T02 > T20 1,174 27.98 <0.001 1,174 19.73 <0.001 1,174 21.706 <0.001 
stability 2-back -> accuracy  -2.78 0.006   2.70 0.008  2.58 0.011 
   (0.274)    (0.252)    (-0.239)  
stability 2-back -> RT  -1.94 0.054   -1.94 0.054  -1.95 0.053 
   (-0.192)    (-0.182)    (-0.181)  
Differential relation to D1 
and D2 expression                   
D1 -> stability 0 back  2.18 0.034   2.212 0.031  3.10 0.003 
   (0.184)    (0.190)    (0.270)  
D1 -> stability 2 back  2.78 0.007   2.978 0.004  3.39 0.001 
   (0.242)    (0.270)    (0.307)  
D2 -> stability 0 back  1.629 0.109  1.963 0.055  0.146 0.149 
   (0.153)   (0.185)   (0.147)  
D2 -> stability 2 back  -0.095 0.924  0071 0.944  0.174 0.862 
  (-0.010)   (0.008)   (0.019)  
D2 -> T02  -2.14 0.037   -2.33 0.023  -2.07 0.043 
   (-0.076)    (-0.09)    (-0.07)  
D2 -> T20  -1.87 0.068   -1.83 0.073  -2.16 0.036 
   (-0.134)    (-0.134)    (-0.152)  
D1 -> T02  -0.996 0.324  -1.066 0.291  -0.832 0.414 
   (-0.037)   (-0.045)   (-0.029)  
D1 -> T20  -0.817 0.418  -0.650 0.519  -0.376 0.709 
  (-0.06)   (-0.049)   (-0.028)  
Drug effect on transition 
energy            
Pla vs. Ami 1,10 7.272 0.022 1,10 4.954 0.05 1,10 8.839 0.014 
Pla vs. Ris 1,10 3.49 0.091 1,10 3.797 0.08 1,10 3.014 0.113 
Drug effect on stability          
Pla vs. Ami 1,8 0.715 0.422 1,8 0.698 0.428 1,8 0.013 0.913 
Pla vs. Ris 1,8 1.057 0.334 1,8 2.941 0.125 1,8 0.358 0.566 
Schizophrenia            
stability 2-back: HC vs. SZ 1,98 6.436 0.013 1,98 6.552 0.012 1,98 4.951 0.028 
stability 0-back: HC vs. SZ 1,98 0.041 0.840 1,98 0.105 0.746 1,98 0.327 0.569 
T02: HC vs. SZ 1,98 5.238 0.024 1,98 6.414 0.013 1,98 5.070 0.027 
T20: HC vs. SZ 1,98 0.620 0.433 1,98 0.534 0.467 1,98 0.275 0.601 
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Abbreviations: FA = structural edge weight defined as mean fraction anisotropy of a track connecting two 
regions; Count =  structural edge weight defined as track count connecting two regions; Gordon = resting-
state defined atlas with 333 regions; T02 = control energy for the transition 0 to 2-back;  T20 = control 
energy for the transition 2 to 0-back; -> = predicts in a regression model; Q = modularity estimate; Pla = 
Placebo; Ami = Amisulpride; Ris = Risperidone; HC = healthy control; SZ = schizophrenia patients. 
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11.4. Table S4: List of brain regions included in the extended Glasser parcellation 
#	 Brain	Region	Label	
1	 Glasser_L_V1	
2	 Glasser_L_MST	
3	 Glasser_L_V6	
4	 Glasser_L_V2	
5	 Glasser_L_V3	
6	 Glasser_L_V4	
7	 Glasser_L_V8	
8	 Glasser_L_4	
9	 Glasser_L_3b	
10	 Glasser_L_FEF	
11	 Glasser_L_PEF	
12	 Glasser_L_55b	
13	 Glasser_L_V3A	
14	 Glasser_L_RSC	
15	 Glasser_L_POS2	
16	 Glasser_L_V7	
17	 Glasser_L_IPS1	
18	 Glasser_L_FFC	
19	 Glasser_L_V3B	
20	 Glasser_L_LO1	
21	 Glasser_L_LO2	
22	 Glasser_L_PIT	
23	 Glasser_L_MT	
24	 Glasser_L_A1	
25	 Glasser_L_PSL	
26	 Glasser_L_SFL	
27	 Glasser_L_PCV	
28	 Glasser_L_STV	
29	 Glasser_L_7Pm	
30	 Glasser_L_7m	
31	 Glasser_L_POS1	
32	 Glasser_L_23d	
33	 Glasser_L_v23ab	
34	 Glasser_L_d23ab	
35	 Glasser_L_31pv	
36	 Glasser_L_5m	
37	 Glasser_L_5mv	
38	 Glasser_L_23c	
39	 Glasser_L_5L	
40	 Glasser_L_24dd	
41	 Glasser_L_24dv	
42	 Glasser_L_7AL	
43	 Glasser_L_SCEF	
44	 Glasser_L_6ma	
45	 Glasser_L_7Am	
46	 Glasser_L_7PL	
47	 Glasser_L_7PC	
48	 Glasser_L_LIPv	
49	 Glasser_L_VIP	
50	 Glasser_L_MIP	
51	 Glasser_L_1	
52	 Glasser_L_2	
53	 Glasser_L_3a	
54	 Glasser_L_6d	
55	 Glasser_L_6mp	
56	 Glasser_L_6v	
57	 Glasser_L_p24pr	
58	 Glasser_L_33pr	
59	 Glasser_L_a24pr	
60	 Glasser_L_p32pr	
61	 Glasser_L_a24	
62	 Glasser_L_d32	
63	 Glasser_L_8BM	
64	 Glasser_L_p32	
65	 Glasser_L_10r	
66	 Glasser_L_47m	
67	 Glasser_L_8Av	
68	 Glasser_L_8Ad	
69	 Glasser_L_9m	
70	 Glasser_L_8BL	
71	 Glasser_L_9p	
72	 Glasser_L_10d	
73	 Glasser_L_8C	
74	 Glasser_L_44	
75	 Glasser_L_45	
76	 Glasser_L_47l	
77	 Glasser_L_a47r	
78	 Glasser_L_6r	
79	 Glasser_L_IFJa	
80	 Glasser_L_IFJp	
81	 Glasser_L_IFSp	
82	 Glasser_L_IFSa	
83	 Glasser_L_p9-46v	
84	 Glasser_L_46	
85	 Glasser_L_a9-46v	
86	 Glasser_L_9-46d	
87	 Glasser_L_9a	
88	 Glasser_L_10v	
89	 Glasser_L_a10p	
90	 Glasser_L_10pp	
91	 Glasser_L_11l	
92	 Glasser_L_13l	
93	 Glasser_L_OFC	
94	 Glasser_L_47s	
95	 Glasser_L_LIPd	
96	 Glasser_L_6a	
97	 Glasser_L_i6-8	
98	 Glasser_L_s6-8	
99	 Glasser_L_43	
100	 Glasser_L_OP4	
101	 Glasser_L_OP1	
102	 Glasser_L_OP2-3	
103	 Glasser_L_52	
104	 Glasser_L_RI	
105	 Glasser_L_PFcm	
106	 Glasser_L_PoI2	
107	 Glasser_L_TA2	
108	 Glasser_L_FOP4	
109	 Glasser_L_MI	
110	 Glasser_L_Pir	
111	 Glasser_L_AVI	
112	 Glasser_L_AAIC	
113	 Glasser_L_FOP1	
114	 Glasser_L_FOP3	
115	 Glasser_L_FOP2	
116	 Glasser_L_PFt	
117	 Glasser_L_AIP	
118	 Glasser_L_EC	
119	 Glasser_L_PreS	
120	 Glasser_L_H	
121	 Glasser_L_ProS	
122	 Glasser_L_PeEc	
123	 Glasser_L_STGa	
124	 Glasser_L_PBelt	
125	 Glasser_L_A5	
126	 Glasser_L_PHA1	
127	 Glasser_L_PHA3	
128	 Glasser_L_STSda	
129	 Glasser_L_STSdp	
130	 Glasser_L_STSvp	
131	 Glasser_L_TGd	
132	 Glasser_L_TE1a	
133	 Glasser_L_TE1p	
134	 Glasser_L_TE2a	
135	 Glasser_L_TF	
136	 Glasser_L_TE2p	
137	 Glasser_L_PHT	
138	 Glasser_L_PH	
139	 Glasser_L_TPOJ1	
140	 Glasser_L_TPOJ2	
141	 Glasser_L_TPOJ3	
142	 Glasser_L_DVT	
143	 Glasser_L_PGp	
144	 Glasser_L_IP2	
145	 Glasser_L_IP1	
146	 Glasser_L_IP0	
147	 Glasser_L_PFop	
148	 Glasser_L_PF	
149	 Glasser_L_PFm	
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150	 Glasser_L_PGi	
151	 Glasser_L_PGs	
152	 Glasser_L_V6A	
153	 Glasser_L_VMV1	
154	 Glasser_L_VMV3	
155	 Glasser_L_PHA2	
156	 Glasser_L_V4t	
157	 Glasser_L_FST	
158	 Glasser_L_V3CD	
159	 Glasser_L_LO3	
160	 Glasser_L_VMV2	
161	 Glasser_L_31pd	
162	 Glasser_L_31a	
163	 Glasser_L_VVC	
164	 Glasser_L_25	
165	 Glasser_L_s32	
166	 Glasser_L_pOFC	
167	 Glasser_L_PoI1	
168	 Glasser_L_Ig	
169	 Glasser_L_FOP5	
170	 Glasser_L_p10p	
171	 Glasser_L_p47r	
172	 Glasser_L_TGv	
173	 Glasser_L_MBelt	
174	 Glasser_L_LBelt	
175	 Glasser_L_A4	
176	 Glasser_L_STSva	
177	 Glasser_L_TE1m	
178	 Glasser_L_PI	
179	 Glasser_L_a32pr	
180	 Glasser_L_p24	
181	 Glasser_R_V1	
182	 Glasser_R_MST	
183	 Glasser_R_V6	
184	 Glasser_R_V2	
185	 Glasser_R_V3	
186	 Glasser_R_V4	
187	 Glasser_R_V8	
188	 Glasser_R_4	
189	 Glasser_R_3b	
190	 Glasser_R_FEF	
191	 Glasser_R_PEF	
192	 Glasser_R_55b	
193	 Glasser_R_V3A	
194	 Glasser_R_RSC	
195	 Glasser_R_POS2	
196	 Glasser_R_V7	
197	 Glasser_R_IPS1	
198	 Glasser_R_FFC	
199	 Glasser_R_V3B	
200	 Glasser_R_LO1	
201	 Glasser_R_LO2	
202	 Glasser_R_PIT	
203	 Glasser_R_MT	
204	 Glasser_R_A1	
205	 Glasser_R_PSL	
206	 Glasser_R_SFL	
207	 Glasser_R_PCV	
208	 Glasser_R_STV	
209	 Glasser_R_7Pm	
210	 Glasser_R_7m	
211	 Glasser_R_POS1	
212	 Glasser_R_23d	
213	 Glasser_R_v23ab	
214	 Glasser_R_d23ab	
215	 Glasser_R_31pv	
216	 Glasser_R_5m	
217	 Glasser_R_5mv	
218	 Glasser_R_23c	
219	 Glasser_R_5L	
220	 Glasser_R_24dd	
221	 Glasser_R_24dv	
222	 Glasser_R_7AL	
223	 Glasser_R_SCEF	
224	 Glasser_R_6ma	
225	 Glasser_R_7Am	
226	 Glasser_R_7PL	
227	 Glasser_R_7PC	
228	 Glasser_R_LIPv	
229	 Glasser_R_VIP	
230	 Glasser_R_MIP	
231	 Glasser_R_1	
232	 Glasser_R_2	
233	 Glasser_R_3a	
234	 Glasser_R_6d	
235	 Glasser_R_6mp	
236	 Glasser_R_6v	
237	 Glasser_R_p24pr	
238	 Glasser_R_33pr	
239	 Glasser_R_a24pr	
240	 Glasser_R_p32pr	
241	 Glasser_R_a24	
242	 Glasser_R_d32	
243	 Glasser_R_8BM	
244	 Glasser_R_p32	
245	 Glasser_R_10r	
246	 Glasser_R_47m	
247	 Glasser_R_8Av	
248	 Glasser_R_8Ad	
249	 Glasser_R_9m	
250	 Glasser_R_8BL	
251	 Glasser_R_9p	
252	 Glasser_R_10d	
253	 Glasser_R_8C	
254	 Glasser_R_44	
255	 Glasser_R_45	
256	 Glasser_R_47l	
257	 Glasser_R_a47r	
258	 Glasser_R_6r	
259	 Glasser_R_IFJa	
260	 Glasser_R_IFJp	
261	 Glasser_R_IFSp	
262	 Glasser_R_IFSa	
263	 Glasser_R_p9-46v	
264	 Glasser_R_46	
265	 Glasser_R_a9-46v	
266	 Glasser_R_9-46d	
267	 Glasser_R_9a	
268	 Glasser_R_10v	
269	 Glasser_R_a10p	
270	 Glasser_R_10pp	
271	 Glasser_R_11l	
272	 Glasser_R_13l	
273	 Glasser_R_OFC	
274	 Glasser_R_47s	
275	 Glasser_R_LIPd	
276	 Glasser_R_6a	
277	 Glasser_R_i6-8	
278	 Glasser_R_s6-8	
279	 Glasser_R_43	
280	 Glasser_R_OP4	
281	 Glasser_R_OP1	
282	 Glasser_R_OP2-3	
283	 Glasser_R_52	
284	 Glasser_R_RI	
285	 Glasser_R_PFcm	
286	 Glasser_R_PoI2	
287	 Glasser_R_TA2	
288	 Glasser_R_FOP4	
289	 Glasser_R_MI	
290	 Glasser_R_Pir	
291	 Glasser_R_AVI	
292	 Glasser_R_AAIC	
293	 Glasser_R_FOP1	
294	 Glasser_R_FOP3	
295	 Glasser_R_FOP2	
296	 Glasser_R_PFt	
297	 Glasser_R_AIP	
298	 Glasser_R_EC	
299	 Glasser_R_PreS	
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300	 Glasser_R_H	
301	 Glasser_R_ProS	
302	 Glasser_R_PeEc	
303	 Glasser_R_STGa	
304	 Glasser_R_PBelt	
305	 Glasser_R_A5	
306	 Glasser_R_PHA1	
307	 Glasser_R_PHA3	
308	 Glasser_R_STSda	
309	 Glasser_R_STSdp	
310	 Glasser_R_STSvp	
311	 Glasser_R_TGd	
312	 Glasser_R_TE1a	
313	 Glasser_R_TE1p	
314	 Glasser_R_TE2a	
315	 Glasser_R_TF	
316	 Glasser_R_TE2p	
317	 Glasser_R_PHT	
318	 Glasser_R_PH	
319	 Glasser_R_TPOJ1	
320	 Glasser_R_TPOJ2	
321	 Glasser_R_TPOJ3	
322	 Glasser_R_DVT	
323	 Glasser_R_PGp	
324	 Glasser_R_IP2	
325	 Glasser_R_IP1	
326	 Glasser_R_IP0	
327	 Glasser_R_PFop	
328	 Glasser_R_PF	
329	 Glasser_R_PFm	
330	 Glasser_R_PGi	
331	 Glasser_R_PGs	
332	 Glasser_R_V6A	
333	 Glasser_R_VMV1	
334	 Glasser_R_VMV3	
335	 Glasser_R_PHA2	
336	 Glasser_R_V4t	
337	 Glasser_R_FST	
338	 Glasser_R_V3CD	
339	 Glasser_R_LO3	
340	 Glasser_R_VMV2	
341	 Glasser_R_31pd	
342	 Glasser_R_31a	
343	 Glasser_R_VVC	
344	 Glasser_R_25	
345	 Glasser_R_s32	
346	 Glasser_R_pOFC	
347	 Glasser_R_PoI1	
348	 Glasser_R_Ig	
349	 Glasser_R_FOP5	
350	 Glasser_R_p10p	
351	 Glasser_R_p47r	
352	 Glasser_R_TGv	
353	 Glasser_R_MBelt	
354	 Glasser_R_LBelt	
355	 Glasser_R_A4	
356	 Glasser_R_STSva	
357	 Glasser_R_TE1m	
358	 Glasser_R_PI	
359	 Glasser_R_a32pr	
360	 Glasser_R_p24	
504	 HO_Left_Thalamus	
505	 HO_Left_Caudate	
506	 HO_Left_Putamen	
507	 HO_Left_Pallidum	
509	 HO_Left_Hippocampus	
510	 HO_Left_Amygdala	
511	 HO_Left_Accumbens	
515	 HO_Right_Thalamus	
516	 HO_Right_Caudate	
517	 HO_Right_Putamen	
518	 HO_Right_Pallidum	
519	 HO_Right_Hippocampus	
520	 HO_Right_Amygdala	
521	 HO_Right_Accumbens	
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